Table of contents

February 2005 Volume 2 No 2

Top

Editorial

Should we afford implantable cardioverter defibrillator therapy?

A John Camm

59

doi:10.1038/ncpcardio0122 | Full Text | PDF (47K)

Top

Viewpoint

Will heart valve tissue engineering change the world?

M H Yacoub and J J M Takkenberg

60

doi:10.1038/ncpcardio0112 | Full Text | PDF (65K)

Top

Research Highlights

Management of atrial fibrillation in congestive heart failure patients

62

doi:10.1038/ncpcardio0101 | Full Text | PDF (60K)

Prophylactic ICD therapy after MI: no survival benefit

62

doi:10.1038/ncpcardio0102 | Full Text | PDF (60K)

Drug-eluting stents for small vessel revascularization

62

doi:10.1038/ncpcardio0103 | Full Text | PDF (67K)

Plasma NT-BNP as a marker of cardiac pump dysfunction

63

doi:10.1038/ncpcardio0104 | Full Text | PDF (58K)

Invasive treatment of angina: a cost-effectiveness study

63

doi:10.1038/ncpcardio0105 | Full Text | PDF (58K)

Intravenous midazolam sedation for cardioversion

64

doi:10.1038/ncpcardio0106 | Full Text | PDF (60K)

Occupational therapy improves outdoor mobility in stroke patients

64

doi:10.1038/ncpcardio0107 | Full Text | PDF (60K)

A noninvasive test for endothelial dysfunction

64

doi:10.1038/ncpcardio0108 | Full Text | PDF (67K)

Advances in coronary angiography

65

doi:10.1038/ncpcardio0109 | Full Text | PDF (60K)

Does statin therapy prevent myocardial injury following PCI?

65

doi:10.1038/ncpcardio0110 | Full Text | PDF (68K)

Antihypertensive agents and cardiovascular outcomes

66

doi:10.1038/ncpcardio0111 | Full Text | PDF (60K)

The Polymeal: a dietary approach to cardiovascular disease prevention

66

doi:10.1038/ncpcardio0119 | Full Text | PDF (60K)

Acute infection linked to increased risk of vascular events

67

doi:10.1038/ncpcardio0120 | Full Text | PDF (58K)

Alcohol and CHD risk

67

doi:10.1038/ncpcardio0121 | Full Text | PDF (58K)

Top

Practice Points

Is antitachycardia pacing a safe and efficacious alternative to shocks for fast ventricular tachyarrhythmia treatment?

Derek V Exner

68

doi:10.1038/ncpcardio0116 | Full Text | PDF (66K)

Should chronic heart failure patients with reduced left-ventricular ejection fraction receive angiotensin-receptor blockers?

Bertram Pitt

70

doi:10.1038/ncpcardio0099 | Full Text | PDF (67K)

Do serum B-type natriuretic peptide levels predict short-term mortality and angiographic success?

Saihari Sadanandan

72

doi:10.1038/ncpcardio0114 | Full Text | PDF (72K)

Does surgical ventricular restoration improve survival in patients with anterior infarction congestive heart failure?

Tadashi Isomura

74

doi:10.1038/ncpcardio0115 | Full Text | PDF (71K)

Can oral sirolimus therapy prevent in-stent restenosis?

Thomas M Schiele

76

doi:10.1038/ncpcardio0078 | Full Text | PDF (72K)

Is there a link between carotid artery stiffness and risk of cerebrovascular events?

Peter M Rothwell

78

doi:10.1038/ncpcardio0113 | Full Text | PDF (68K)

Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?

Giancarlo Marenzi

80

doi:10.1038/ncpcardio0098 | Full Text | PDF (66K)

Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?

Francisco Perez-Gomez

82

doi:10.1038/ncpcardio0117 | Full Text | PDF (68K)

Top

Reviews

Short QT syndrome: mechanisms, diagnosis and treatment

Preben Bjerregaard and Ihor Gussak

84

doi:10.1038/ncpcardio0097 | Full Text | PDF (235K)

Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction

Richard O Cannon III

88

doi:10.1038/ncpcardio0096 | Full Text | PDF (114K)

Therapy Insight: congestive heart failure, chronic kidney disease and anemia, the cardio–renal–anemia syndrome

Adrian Iaina, Donald S Silverberg and Dov Wexler

95

doi:10.1038/ncpcardio0094 | Full Text | PDF (130K)

Technology Insight: transcoronary ablation of septal hypertrophy

Haran Burri and Ulrich Sigwart

101

doi:10.1038/ncpcardio0095 | Full Text | PDF (246K)

Top

Case Study

Continuing Medical Education

Pulmonary artery sarcoma masquerading as chronic thromboembolic pulmonary hypertension

Kim M Kerr

108

doi:10.1038/ncpcardio0118 | Full Text | PDF (319K)

Extra navigation

.

ADVERTISEMENT